Related Experiment Video
Updated: Jan 14, 2026

07:42
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
3.6K
Development of a Prognostic Model for Poststroke Dementia Using Multiple International Cohorts: A STROKOG
Jessica W Lo1, John D Crawford1, David W Desmond2
1Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, Australia.
Neurology
|January 12, 2026
Summary
A new dementia risk model predicts 5-year risk in stroke survivors using common clinical data. This tool aids in identifying high-risk individuals for better cognitive monitoring and outcomes.
Area of Science:
- Neurology
- Epidemiology
- Biostatistics
Background:
- General dementia risk models perform poorly in stroke survivors.
- Existing stroke-specific models are limited in scope and accessibility.
- Need for a clinically practical dementia risk prediction tool for post-stroke patients.
Purpose of the Study:
- To develop a clinically practical model for predicting 5-year dementia risk after stroke.
- Utilize commonly available variables and individual participant data.
- Leverage data from the Stroke and Cognition Consortium (STROKOG).
Main Methods:
- Pooled data from 12 international studies.
- Employed Fine-Gray subdistribution hazard models accounting for competing risks (death).
- Utilized backward stepwise elimination for predictor selection and internal-external cross-validation (IECV) for generalizability assessment.
Main Results:
- Developed a model including age, sex, education, prior stroke, diabetes, stroke severity, and interactions.
- The model demonstrated strong discrimination (C-index: 0.81) and excellent calibration in the development dataset.
- IECV showed acceptable discrimination across studies (pooled C-index: 0.70), performing better in recent and European cohorts.
Conclusions:
- A validated 5-year dementia risk model for stroke survivors was developed using routine clinical variables.
- The model shows good generalizability, particularly in recent and European cohorts.
- This tool can facilitate targeted cognitive monitoring, improve clinical decision-making, and enhance long-term patient outcomes.

